Featuring Andrea Wainer, Executive Vice President, Rapid and Molecular Diagnostics, Abbott.
Andrea Wainer is Abbott’s Executive Vice President, Rapid and Molecular Diagnostics. She was appointed to this role in June 2019.
Andrea joined Abbott in 1997 and served in a variety of roles within our pharmaceuticals business, including divisional vice president and general manager, renal care. She then led our Animal Health business, which was acquired by Zoetis in February 2015. Immediately prior to assuming her current responsibilities, Andrea served as Vice President, Molecular Diagnostics.
In her current role, Andrea leads four innovative businesses; one a leader in molecular diagnostics and the analysis of DNA and RNA at the molecular level; another the world’s leading provider of rapid point-of-care diagnostics; a third providing a leading hand-held point of care device; and finally, a world-class informatics solution provider. Each of these offers products that provide clinicians with actionable information that can contribute to better clinical, operational and economic outcomes.
Andrea earned her bachelor’s degree in accounting from the John M. Olin School of Business, Washington University, St. Louis, Missouri, and her Masters in Business Administration from the Kellogg School of Management, Northwestern University in Evanston, Illinois.
BioPathways is a monthly event series, featuring prominent bioentrepreneurs, biotech executives, and biotech investors in a fireside chat.